top of page

Our single objective: to prevent and reverse disability for everyone with multiple sclerosis, neuromyelitis optica and MOG associated disease.

Our Research Themes
Latest News
Interim Octopus Trial Results Show Potential for Alpha-lipoic Acid as a Treatment for Progressive Multiple Sclerosis
​​17th September 2026
We are excited by the fantastic interim results from the Octopus trial announced today, as alpha-lipoic acid has shown an initial positive effect in progressive multiple sclerosis and will be continued into further stages.​​


Public Collaborators
​
​
We recognise that we cannot truly understand the needs of people living with MS in our community unless our Public Collaborators Council has representatives from diverse backgrounds and life experiences, including often overlooked groups.

bottom of page
















